New insights into the pathogenesis of preeclampsia - The role of Nrf2 activators and their potential therapeutic impact

Geburtshilfe und Frauenheilkunde

Volumn 73, Issue 12, 2013, Pages 1236-1240

  Kweider, N ^a   Wruck, C J ^a   Rath, W ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

heme oxygenase 1; Nrf2; preeclampsia

Indexed keywords

HEME OXYGENASE 1; TRANSCRIPTION FACTOR NRF2; VASCULOTROPIN;

ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; HYPOTENSION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PREECLAMPSIA; PREGNANCY;

EID: 84896534877     PISSN: 00165751     EISSN: 14388804     Source Type: Journal    
DOI: 10.1055/s-0033-1360133     Document Type: Article

References (60)

1. Steegers E. A., von Dadelszen P., Duvekot J. J. et al. Pre-eclampsia. Lancet: 2010; 376 631 644
2. Cantwell R., Clutton-Brock T., Cooper G. et al. Saving Mothers Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG: 2011; 118 01 1 203
3. ACOG ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Obstet Gynecol: 2002; 99 159 167
4. Brown M. C., Best K. E., Pearce M. S. et al. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol: 2013; 28 1 19
5. Schausberger C. E., Jacobs V. R., Bogner G. et al. Hypertensive disorders of pregnancy - a life-long risk? Geburtsh Frauenheilk: 2013; 73 47 52
6. van Rijn B. B., Nijdam M. E., Bruinse H. W. et al. Cardiovascular disease risk factors in women with a history of early-onset preeclampsia. Obstet Gynecol: 2013; 121 1040 1048
7. Schlembach D. Pre-eclampsia-still a disease of theories. Fukushima J Med Sci: 2003; 49 69 115
8. Tallarek A-C, Huppertz B., Stepan H. Preeclampsia - aetiology, current diagnostics and clinical management, new therapy options and future perspectives. Geburtsh Frauenheilk: 2012; 72 1107 1116
9. Redman C. W., Sargent I. L. Latest advances in understanding preeclampsia. Science: 2005; 308 1592 1594 (Pubitemid 40807500)
10. Kaufmann P., Black S., Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod: 2003; 69 1 7 (Pubitemid 36806800)
11. Murray A. J. Oxygen delivery and fetal-placental growth: beyond a question of supply and demand? Placenta: 2012; 33 02 e16 e22
12. Vanderlelie J., Venardos K., Clifton V. L. et al. Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta: 2005; 26 53 58 (Pubitemid 40123676)
13. Kaspar J. W., Niture S. K., Jaiswal A. K. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med: 2009; 47 1304 1309
14. Wruck C. J., Streetz K., Pavic G. et al. Nrf2 induces interleukin-6 (IL-6) expression via an antioxidant response element within the IL-6 promoter. J Biol Chem: 2011; 286 4493 4499
15. Kensler T. W., Wakabayashi N., Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol: 2007; 47 89 116
16. Wruck C. J., Huppertz B., Bose P. et al. Role of a fetal defence mechanism against oxidative stress in the aetiology of preeclampsia. Histopathology: 2009; 55 102 106
17. Kweider N., Fragoulis A., Rosen C. et al. Interplay between vascular endothelial growth factor (VEGF) and nuclear factor erythroid 2-related factor-2 (Nrf2): implications for preeclampsia. J Biol Chem: 2011; 286 42863 42872
18. Kweider N., Huppertz B., Wruck C. J. et al. A role for Nrf2 in redox signalling of the invasive extravillous trophoblast in severe early onset IUGR associated with preeclampsia. PloS One: 2012; 7 e47055
19. Belo L., Caslake M., Santos-Silva A. et al. LDL size, total antioxidant status and oxidised LDL in normal human pregnancy: a longitudinal study. Atherosclerosis: 2004; 177 391 399 (Pubitemid 39505273)
20. Redman C. W. Preeclampsia: a multi-stress disorder. Rev Med Interne: 2011; 32 01 S41 S44
21. Burton G. J., Jauniaux E. Oxidative stress. Best Pract Res Clin Obstet Gynaecol: 2011; 25 287 299
22. Roberts J. M., Taylor R. N., Musci T. J. et al. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol: 1989; 161 1200 1204 (Pubitemid 20007682)
23. Huppertz B., Abe E., Murthi P. et al. Placental angiogenesis, maternal and fetal vessels - a workshop report. Placenta: 2007; 28 (Suppl. A) S94 S96 (Pubitemid 46506057)
24. Kadyrov M., Kingdom J. C., Huppertz B. Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction. Am J Obstet Gynecol: 2006; 194 557 563 (Pubitemid 43183716)
25. Miranda Guisado M. L., Vallejo-Vaz A. J., Garcia Junco P. S. et al. Abnormal levels of antioxidant defenses in a large sample of patients with hypertensive disorders of pregnancy. Hypertens Res: 2012; 35 274 278
26. Stepan H., Heihoff-Klose A., Faber R. Reduced antioxidant capacity in second-trimester pregnancies with pathological uterine perfusion. Ultrasound Obstet Gynecol: 2004; 23 579 583 (Pubitemid 38829867)
27. Roberts J. M., Hubel C. A. Is oxidative stress the link in the two-stage model of pre-eclampsia? Lancet: 1999; 354 788 789 (Pubitemid 29415578)
28. Hung T. H., Skepper J. N., Burton G. J. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol: 2001; 159 1031 1043 (Pubitemid 32847193)
29. Taguchi K., Motohashi H., Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells: 2011; 16 123 140
30. Lee J. M., Li J., Johnson D. A. et al. Nrf2, a multi-organ protector? FASEB J: 2005; 19 1061 1066
31. Brandenburg L. O., Kipp M., Lucius R. et al. Sulforaphane suppresses LPS-induced inflammation in primary rat microglia. Inflamm Res: 2010; 59 443 450
32. Chigusa Y., Tatsumi K., Kondoh E. et al. Decreased lectin-like oxidized LDL receptor 1 (LOX-1) and low Nrf2 activation in placenta are involved in preeclampsia. J Clin Endocrinol Metab: 2012; 97 E1862 E1870
33. Mann G. E., Niehueser-Saran J., Watson A. et al. Nrf2/ARE regulated antioxidant gene expression in endothelial and smooth muscle cells in oxidative stress: implications for atherosclerosis and preeclampsia. Sheng Li Xue Bao: 2007; 59 117 127
34. Valcarcel-Ares M. N., Gautam T., Warrington J. P. et al. Disruption of Nrf2 signaling impairs angiogenic capacity of endothelial cells: implications for microvascular aging. J Gerontol A Biol Sci Med Sci: 2012; 67 821 829
35. Loset M., Mundal S. B., Johnson M. P. et al. A transcriptional profile of the decidua in preeclampsia. Am J Obstet Gynecol: 2011; 204 84e81 84e27
36. Bilban M., Haslinger P., Prast J. et al. Identification of novel trophoblast invasion-related genes: heme oxygenase-1 controls motility via peroxisome proliferator-activated receptor gamma. Endocrinology: 2009; 150 1000 1013
37. Barbagallo I., Galvano F., Frigiola A. et al. Potential therapeutic effects of natural heme oxygenase-1 inducers in cardiovascular diseases. Antioxid Redox Signal: 2013; 18 507 521
38. Tenhunen R., Marver H. S., Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci U S A: 1968; 61 748 755
39. Levytska K., Kingdom J., Baczyk D. et al. Heme oxygenase-1 in placental development and pathology. Placenta: 2013; 34 291 298
40. Cudmore M., Ahmad S., Al-Ani B. et al. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation: 2007; 115 1789 1797 (Pubitemid 46648616)
41. Verlohren S., Herraiz I., Lapaire O. et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol: 2012; 206 58e51 58e58
42. Stepan H., Ebert T., Schrey S. et al. Serum levels of angiopoietin-related growth factor are increased in preeclampsia. Am J Hypertens: 2009; 22 314 318
43. Stepan H. Angiogenic factors and pre-eclampsia: an early marker is needed. Clin Sci: 2009; 116 231 232
44. Fasshauer M., Waldeyer T., Seeger J. et al. Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function. Eur J Endocrinol: 2008; 158 197 201 (Pubitemid 351298536)
45. George E. M., Hosick P. A., Stec D. E. et al. Heme oxygenase inhibition increases blood pressure in pregnant rats. Am J Hypertens: 2013; 26 924 930
46. Grochot-Przeczek A., Dulak J., Jozkowicz A. Heme oxygenase-1 in neovascularisation: a diabetic perspective. Thromb Haemost: 2010; 104 424 431
47. Zhao H., Wong R. J., Kalish F. S. et al. Effect of heme oxygenase-1 deficiency on placental development. Placenta: 2009; 30 861 868
48. Grosser N., Hemmerle A., Berndt G. et al. The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radic Biol Med: 2004; 37 2064 2071 (Pubitemid 39491325)
49. Deng Y. M., Wu B. J., Witting P. K. et al. Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1. Circulation: 2004; 110 1855 1860 (Pubitemid 39299229)
50. Wruck C. J., Gotz M. E., Herdegen T. et al. Kavalactones protect neural cells against amyloid beta peptide-induced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation. Mol Pharmacol: 2008; 73 1785 1795 (Pubitemid 351724366)
51. Wu L., Juurlink B. H. The impaired glutathione system and its up-regulation by sulforaphane in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens: 2001; 19 1819 1825 (Pubitemid 32924948)
52. Guan S. P., Tee W., Ng D. S. et al. Andrographolide protects against cigarette smoke-induced oxidative lung injury via augmentation of Nrf2 activity. Br J Pharmacol: 2013; 168 1707 1718
53. Poston L., Briley A. L., Seed P. T. et al. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet: 2006; 367 1145 1154
54. Rumbold A. R., Crowther C. A., Haslam R. R. et al. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med: 2006; 354 1796 1806
55. 2 as possible risk factors for preeclampsia - under consideration of the PROPER study (Prevention of preeclampsia by high-dose riboflavin supplementation). Geburtsh Frauenheilk: 2012; 72 846 852
56. Voelkel N. F., Bogaard H. J., Al Husseini A. et al. Antioxidants for the treatment of patients with severe angioproliferative pulmonary hypertension? Antioxid Redox Signal: 2013; 18 1810 1817
57. Gomez-Guzman M., Jimenez R., Sanchez M. et al. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension. Free Radic Biol Med: 2012; 52 70 79
58. Kim S. B., Eskiocak U., Ly P. Bardoxolone-methyl (CDDO-Me): an antioxidant, antiinflammatory modulator is a novel radiation countermeasure and mitigator. In: Proceedings of the 22nd Annual NASA Space Radiation Investigators Workshop 2011; Sep 2011.
59. Rojas-Rivera J., Ortiz A., Egido J. Antioxidants in kidney diseases: the impact of bardoxolone methyl. Int J Nephrol: 2012; 2012 321714
60. Vanhees K., van Schooten F. J., van Waalwijk van Doorn-Khosrovani S. B. et al. Intrauterine exposure to flavonoids modifies antioxidant status at adulthood and decreases oxidative stress-induced DNA damage. Free Radic Biol Med: 2013; 57 154 161